Czech Blue-Chip Pharma Zentiva Sees Net Profit Rise 16.4% Y/Y To CZK 1.9Bln In 2005

The Czech Republic's top pharmaceutical producer Zentiva saw its net profit increase 16.4% year on year (y/y) to CZK 1.87 bln in 2005 in line with company forecasts, Zentiva CEO Jiri Michal announced in a statement on Monday.